摘要
目的了解多重耐药铜绿假单胞菌(MDRPA)在本院的分布状况及耐药趋势,探讨MDRPA的预防及控制措施。方法采用微生物鉴定及药敏试验系统回顾性分析2007～2010年本院临床送检标本中分离的MDRPA的检出率、分布状况及耐药状况。结果 4年共检出铜绿假单胞菌154株,其中MDRPA有102株,占66.2%,并且MDRPA检出率呈逐年上升的趋势。以脑外科分离的MDRPA为最多,占56.8%,其次是神经内科,占19.6%。4年来,MDRPA除对头孢吡肟和美洛培南保持较高的敏感率外,对其他13种抗生素的耐药率逐年增高。结论应合理使用抗生素,强化医务人员的院感意识,加强对铜绿假单胞菌的监测,最大限度控制MDRPA。
Objective To investigate the distribution and drug resistance of multidrug-resistant preudomonas aeruginosa（MDRPA） in our hospital,and its control measures. Methods The microbiological assay system and susceptibility test card were used to test the detective rate, distribution and drug resistance of postive MDRPA in our hospital from 2007 to 2010. Results Among the 154 preudomonas aeruginosa,there were 102 strains of MDRPA ac- counted for 66.2X ,which showed an up trend in the past four years. The detection rate of MDRPA was highest in neurosurgery department（56. 8~）, followed by the neurology department （19. 6~）. The drug resistant rates of MDRPA to 13 kinds of antibiotics quickly increased except meropenem and cefepime in the past four years. Conclusion We should take the rational use of antibiotics,strengthen the consciousness of medical staff,enhance the monitoring of pseudomonas aeruginosa,and reduce the infection of MDRPA.
出处
《检验医学与临床》
CAS
2013年第3期257-258,共2页
Laboratory Medicine and Clinic
关键词
多重耐药
铜绿假单胞菌
预防
控制
multidrug-resistant
preudomonas aeruginosa
preventions controlling
